Skip to main content


Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease

Fig. 1

Correlations of serum neurofilament light (NfL) levels with relevant variables in mutation carriers. a Estimated years to/from symptom onset (EYO), b Mini-Mental State Examination (MMSE), c Clinical Dementia Rating sum of boxes (CDR-SOB), d cerebrospinal fluid (CSF) NfL, e CSF total tau (T-tau), and f CSF phosphorylated tau (Ptau)

Back to article page